CAS: 1262036-50-9 - N-[3-[(4aS,7aS)-2-Amino-4a,5-dihydro-4H-furo[3,4-d][1,3]thiazin-7a(7H)-yl]-4-fluorophenyl]-5-fluoro-2-pyridinecarboxamide
Formula:C18H16F2N4O2S
InChI:InChI=1S/C18H16F2N4O2S/c19-11-1-4-15(22-6-11)16(25)23-12-2-3-14(20)13(5-12)18-9-26-7-10(18)8-27-17(21)24-18/h1-6,10H,7-9H2,(H2,21,24)(H,23,25)/t10-,18-/m0/s1
InChI key:InChIKey=NIDRNVHMMDAAIK-YPMLDQLKSA-N
SMILES:O=C(NC1=CC=C(F)C(=C1)C23N=C(SCC3COC2)N)C4=NC=C(F)C=C4
- Synonyms:
- 2-Pyridinecarboxamide, N-[3-[(4aS,7aS)-2-amino-4a,5-dihydro-4H-furo[3,4-d][1,3]thiazin-7a(7H)-yl]-4-fluorophenyl]-5-fluoro-
- Ly 2886721
- N-(3-((4As,7as)-2-amino-4A,5,7,7A-tetrahydro-4H-furo[3,4-D][1,3]thiazin-7A-yl)-4-fluorophenyl)-5-fluoropicolinamide
- N-[3-[(4aS,7aS)-2-Amino-4a,5-dihydro-4H-furo[3,4-d][1,3]thiazin-7a(7H)-yl]-4-fluorophenyl]-5-fluoro-2-pyridinecarboxamide
- VTP 37948
- BI 1181181
LY2886721
CAS:1262036-50-9
LY2886721, a BACE inhibitor, is used for the therapy of Alzheimer's Disease.
Formula:
C18H16F2N4O2S
Purity:
99% - 99.94%
Color and Shape:
Solid
Molecular weight:
390.41
Ref: TM-T6058
5mg | 50.00 € | ||
10mg | 78.00 € | ||
25mg | 134.00 € | ||
50mg | 227.00 € | ||
100mg | 338.00 € | ||
200mg | 481.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
LY 2886721 - Bio-X ™
CAS:1262036-50-9
This product is part of our Bio-X ™ Range. These products are aimed at life …
Formula:
C18H16F2N4O2S
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
390.41 g/mol
Ref: 3D-BL300094
10mg | 172.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
LY 2886721
CAS:1262036-50-9
Inhibitor of BACE1 protease
Formula:
C18H16F2N4O2S
Purity:
Min. 98 Area-%
Color and Shape:
Powder
Molecular weight:
390.41 g/mol
Ref: 3D-FL103714
25mg | 178.00 € | ||
50mg | 267.00 € | ||
100mg | 419.00 € | ||
250mg | 740.00 € | ||
500mg | 1,157.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024